HomeOVID • NASDAQ
Ovid Therapeutics Inc
add
$0.31
3.53%
After Hours:(2.42%)+0.0074
$0.31
Closed: May 15, 8:00:00 PM UTC-4 · USD · NASDAQ · Disclaimer
In the news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | 130.00K | -12.16% |
Operating expense | 12.68M | -27.81% |
Net income | -10.24M | 12.48% |
Net profit margin | -7.87K | 0.36% |
Earnings per share | -0.14 | 17.65% |
EBITDA | -12.41M | 28.19% |
Effective tax rate | — | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 43.00M | -52.36% |
Total assets | 81.65M | -37.96% |
Total liabilities | 22.38M | -58.04% |
Total equity | 59.28M | — |
Shares outstanding | 71.11M | — |
Price to book | 0.36 | — |
Return on assets | -36.10% | — |
Return on capital | -40.05% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -10.24M | 12.48% |
Cash from operations | -10.28M | 38.39% |
Cash from investing | 5.10M | -74.73% |
Cash from financing | 13.00K | -94.30% |
Net change in cash | -5.17M | -238.43% |
Free cash flow | -9.00M | 14.60% |
Previous close
$0.29
Day range
$0.29 - $0.31
Year range
$0.24 - $3.41
Market cap
22.08M USD
Avg Volume
367.93K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
About
Founded
2014
Website
Employees
23
